Chicago, IL – June 10, 2025 – Today, Zacks Equity Research discusses Sandoz SDZNY, Teva Pharmaceuticals TEVA and Viatris VTRS ...

President Donald J. Trump has signaled that lowering the costs of prescription drugs will be a priority for his second term.

Switching to Humira biosimilars saved Navitus clients more than $315 million in upfront costs in 2024 and resulted in a 60% ...

McKesson Corporation (NYSE:MCK) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. On June 11, analyst ...

Biosimilars marketed in the US typically have list prices 15% to 35% lower than ... sometimes force diabetics to ration their use of the drugs. Semglee's latest approval follows the publication ...

After digesting Cardinal Health's 2025 investor day, we inched up our 2026 revenue and EPS assumptions and lifted our stage II growth rates by 50 basis points to reflect a stronger distribution market ...

Medicare Advantage will see major changes starting in 2025, cutting drug costs and expanding services—key info for beneficiaries to stay prepared.

Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) in Q1 CY2025, with sales flat year on year at $170.5 million.

United States of America is one of only two countries—along with New Zealand—that allows direct-to-consumer Pharmaceutical ...

“The ability for generic and biosimilar manufacturers to procompetitively settle with brand-name drug manufacturers creates ...

Witnesses at the April 8 hearing told legislators biosimilars save patients and taxpayers money, that pharmacy benefit ...